Cardiac tamponade
diseaseOn this page
Also known as pericardial tamponade
Summary
Cardiac tamponade (MONDO:0001297) is a disease and 7 clinical trials. A subtype of pericardial effusion — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Clinical trials: 7
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | cardiac tamponade |
| Mondo ID | MONDO:0001297 |
| EFO | EFO:1001285 |
| MeSH | D002305 |
| DOID | DOID:115 |
| ICD-10-CM | I31.4 |
| ICD-11 | 216782575 |
| NCIT | C50481 |
| SNOMED CT | 35304003 |
| UMLS | C0007177 |
| MedGen | 40108 |
| Is cancer (heuristic) | no |
Also known as: pericardial tamponade
Disease family
This is a subtype of pericardial effusion. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › cardiovascular disorder › heart disorder › pericardium disorder › pericardial effusion › cardiac tamponade
Related subtypes (2): hemopericardium, pericardial effusion, chronic
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 7.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| Not specified | 7 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT07159269 | Not specified | RECRUITING | Cardiac point-of Care Ultrasound Training Pathway for Emergency Department Advanced Practice Providers |
| NCT00684125 | Not specified | COMPLETED | Evaluation of Different Strategies of Pericardial Drainage After Aortic Valvular Surgery |
| NCT02808897 | Not specified | COMPLETED | Active Clearance of Chest Tubes After Cardiac Surgery: A Prospective Randomized Controlled Study |
| NCT02961439 | Not specified | COMPLETED | Validation of Epworth Richmond’s Echocardiography Education Focused Year |
| NCT05086653 | Not specified | COMPLETED | Complications From Left Atrial Appendage Occluder |
| NCT05308589 | Not specified | TERMINATED | CPPF After General Cardiac Surgery |
| NCT07266935 | Not specified | COMPLETED | Posterior Pericardiotomy for Prevention of POAF After Cardiac Surgery: RCT in Yemen |
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.